Ryan Fischesser Net Worth & Insider Trades
Ryan Fischesser - VP Finance and Controller, Caribou Biosciences, Inc
What is Ryan Fischesser's Net Worth?
The current estimated net worth of Caribou Biosciences, Inc's VP Finance and Controller, Ryan Fischesser, is estimated to be about $1M . Ryan Fischesser owns about 116,044 units of Caribou Biosciences, Inc common stock. In the last year at Caribou Biosciences, Inc, Ryan Fischesser has sold an estimated value of $107.96K worth.
What is Ryan Fischesser's Past Insider Trading?
Ryan Fischesser's largest purchase order was 7,387 units , worth over $29.55K on January 12, 2022. Ryan Fischesser's largest sale order was 10,000 units , worth over $107.96K on October 7, 2022. In total, Ryan Fischesser has made about 7 transactions over a year of their time at Caribou Biosciences, Inc. Ryan Fischesser usually trades in October, with the busiest year in 2022.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ryan Fischesser
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Ryan Fischesser's' Mailing Address?
- Mailing address is Caribou Biociences, Inc. 2929 7th Street, Suite 105 Berkeley CA 94710 CA
What are Caribou Biosciences, Inc's Past Insider Trades?
Caribou Biosciences, Inc's most recent insider trade came on January 20, 2023 by Aliaamir Syed Rizvi who sold 5,627 units worth $35.51K . In the last 2 years, insiders at Caribou Biosciences, Inc have sold an estimated value of $628.69K and bought an estimated value of $971.79K worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Ryan Fischesser, VP Finance and Controller, Steven Kanner, Chief Scientific Officer, and Rachel Haurwitz, President and CEO .
Caribou Biosciences, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |